HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Germany Begins The Year With Two Possible Rx-To-OTC Switches

Executive Summary

Germany's Expert Committee for Prescription will meet on 22 January to consider two prescription-to-OTC switch applications: preparations containing a combination of ibuprofen and phenylephrine hydrochloride and hydrocortisone 1% for external use. 

You may also be interested in...



Surviving The Dark German Winter: Four New Dietary Supplements Containing Vitamin D

To help Germans struggling through the dark winter months, Hevert, Cefak, Stada and Doppelherz have all released vitamin D supplements onto the German market.

Germany Marketing Round Up December 2018: New OTC Products For The Winter Cough and Cold Season

Five new OTC cough and cold products have hit the shelves in Germany this winter from Pari, Pohl Boskamp, Engelhard Arzneimittel, GSK and Dr Soldan.

An Expert’s Guide To Switching In Germany, Part 2: Improving The Reclassification Process

In Part 2 of this exclusive interview, Elmar Kroth, scientific director of the German Medicines Manufacturers´ Association, the BAH, tells HBW Insight what the association is doing to improve the prescription-to-OTC switch process in Germany. 

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS148411

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel